The novel treatment of the medication represents a exciting advance in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide338823.dailyblogzz.com/42497749/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment